{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:06:02Z","timestamp":1774314362962,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.soc.2016.07.007","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T08:02:18Z","timestamp":1479974538000},"page":"127-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Surveillance of Anal Canal Cancers"],"prefix":"10.1016","volume":"26","author":[{"given":"Richard","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.soc.2016.07.007_bib1","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.soc.2016.07.007_bib2","unstructured":"Available at: http:\/\/www.cancer.org\/acs\/groups\/content\/@research\/documents\/document\/acspc-047079.pdf. Accessed April 1, 2016."},{"issue":"Suppl 3","key":"10.1016\/j.soc.2016.07.007_bib3","doi-asserted-by":"crossref","first-page":"iii10","DOI":"10.1093\/annonc\/mdu159","article-title":"Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soc.2016.07.007_bib4","unstructured":"Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/anal.pdf. Accessed April 1, 2016."},{"issue":"6","key":"10.1016\/j.soc.2016.07.007_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00a0\u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soc.2016.07.007_bib6","author":"Severino","year":"2016","journal-title":"Colorectal Dis"},{"issue":"Suppl 4S","key":"10.1016\/j.soc.2016.07.007_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1200\/jco.2016.34.4_suppl.573","article-title":"Post-treatment surveillance in locally advanced squamous cell carcinoma (SCCA) of the anal canal: a global subspecialist survey","volume":"34","author":"Eng","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"Supplement 7","key":"10.1016\/j.soc.2016.07.007_bib8","doi-asserted-by":"crossref","first-page":"vii27","DOI":"10.1093\/annonc\/mds268","article-title":"ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Colombo","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soc.2016.07.007_bib9","unstructured":"Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/cervical.pdf. Accessed August 13, 2016."}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320716300400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320716300400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:01:05Z","timestamp":1760961665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320716300400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1055320716300400"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2016.07.007","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance of Anal Canal Cancers","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2016.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}